Moreover, GPCRs (including ADGRA1, ADGRV1, CELSR2, and S1PR5) previously reported to be implicated in the physiopathology and pharmacology of depression were also significantly altered (Tomita et al., 2013). Here, ADGRA1 is linked to depressive symptom measurement.